| Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. | |
| | |
MedLine Citation:
|
PMID: 10333906 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The purpose of this study was to determine if there are sex differences in African-Americans regarding the effect of obesity on sensitivity to insulin as a glucoregulatory and antilipolytic hormone. RESEARCH DESIGN AND METHODS: Data from study participants, 127 nondiabetic African-Americans (mean age 32 +/- 4 years), included anthropometric measurements, an oral glucose tolerance test (OGTT), a 2-h euglycemic-hyperinsulinemic clamp, and a fasting triglyceride level. Sensitivity to insulin as a glucoregulatory hormone was determined by M/FFM, where M is the mean glucose infusion rate during the second hour of the clamp and FFM is fat-free mass. Sensitivity to insulin's antilipolytic action was assessed during the OGTT by the percent suppression of free fatty acid (FFA) concentrations between 0 and 120 min. The higher the suppression of FFAs, the greater the sensitivity to insulin's antilipolytic action. RESULTS: The participants were classified by BMI into three groups: nonobese (31 men, 24 women), obese (17 men, 14 women), and severely obese (12 men, 29 women). The women had higher percentages of body fat (P < 0.001), and the men had greater FFM (P < 0.001). The M/FFM values for men versus women in each BMI group were nonobese, 8.8 +/- 2.8 vs. 10.8 +/- 4.4; obese, 7.2 +/- 3.4 vs. 8.5 +/- 3.4; and severely obese, 4.7 +/- 2.1 vs. 6.1 +/- 2.2. The difference between the BMI groups was significant (P < 0.001), as was the difference between men and women (P < 0.01). In addition, there was a significant sex difference in percent suppression of FFAS (P < 0.001). The men and women had similar fasting insulin and FFA concentrations; however, in the men only, the percent suppression of FFA declined with increasing obesity (nonobese, 83 +/- 15%; obese, 73 +/- 18%; and severely obese, 69 +/- 19%; P = 0.02). The women in all three BMI groups had lower FFA levels of 86-88%. CONCLUSIONS: Obese African-American men and women are resistant to insulin as a glucoregulatory hormone, but only obese men are resistant to insulin's antilipolytic action; obese African-American women are sensitive to insulin's antilipolytic action. The combined presence of sensitivity to insulin's antilipolytic action with resistance to insulin's glucoregulatory action in obese African-American women may contribute to their high prevalence of obesity and type 2 diabetes. |
| | |
Authors:
|
A E Sumner; H Kushner; K D Sherif; T N Tulenko; B Falkner; J B Marsh |
Related Documents
:
|
19847656 - Does physical activity modify the risk of obesity for type 2 diabetes: a review of epid... 12505756 - The impact of ethnicity on type 2 diabetes. 3812446 - Centralized obesity and cardiovascular disease risk in mexican americans. 12037656 - Eating behavior in obese patients with and without type 2 diabetes mellitus. 11375346 - Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse ... 8720416 - Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Diabetes care Volume: 22 ISSN: 0149-5992 ISO Abbreviation: Diabetes Care Publication Date: 1999 Jan |
Date Detail:
|
Created Date: 1999-07-13 Completed Date: 1999-07-13 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 7805975 Medline TA: Diabetes Care Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 71-7 Citation Subset: IM |
Affiliation:
|
Institute for Women's Health, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA. annes@intra.niddk.nih.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult African Continental Ancestry Group* Analysis of Variance Blood Glucose / drug effects, metabolism* Cohort Studies Female Glucose Clamp Technique Glucose Tolerance Test Homeostasis Humans Hyperinsulinism Infusions, Intravenous Insulin / administration & dosage, pharmacology*, physiology Lipolysis / drug effects* Longitudinal Studies Male Metabolic Clearance Rate Philadelphia Regression Analysis Sex Characteristics |
| Grant Support | |
ID/Acronym/Agency:
|
HL-51536/HL/NHLBI NIH HHS; HL-51547/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 11061-68-0/Insulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese...
Next Document: Social environment and year of birth influence type 1 diabetes risk for African-American and Latino ...